James Courtemanche

James Courtemanche is an experienced quality assurance professional with expertise in Good Manufacturing Practices (GMP). Currently serving as the Director of Quality Assurance at Novo Nordisk since October 2022, James has held similar leadership roles at Forma Therapeutics and Reata Pharmaceuticals, where responsibilities included overseeing quality assurance initiatives. Prior positions at AMAG Pharmaceuticals encompassed roles as Director of Quality Assurance Operations, Associate Director of Quality Control, and Quality Assurance Systems Manager, while earlier experience at AMRI involved ascending from Quality Assurance Specialist to Supervisor. James holds a Bachelor of Science degree in Biology from Salem State University.